These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14430240)

  • 1. Comparative clinical evaluation of two alkylating agents: mannitol mustard and cyclophosphamide (cytoxan).
    PAPAC R; PETRAKIS NL; AMINI F; WOOD DA
    J Am Med Assoc; 1960 Mar; 172():1387-91. PubMed ID: 14430240
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
    LASZLO J; GRIZZLE J; JONSSON U; RUNDLES RW
    Cancer Chemother Rep; 1962 Feb; 16():247-50. PubMed ID: 14462650
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of a new alkylating agent: cytoxan (cyclophosphamide).
    COGGINS PR; RAVDIN RG; EISMAN SH
    Cancer; 1960; 13():1254-60. PubMed ID: 13694297
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL; SALVIN LG; SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF HEPARIN-BOUND ALKYLATING AGENTS AND ENZYME INHIBITORS ON NEOPLASTIC GROWTH.
    CSABA G; KOROESI J; HORVATH C; MOLD K; ACS T
    Neoplasma; 1964; 11():137-44. PubMed ID: 14160693
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide. A preliminary study of a new alkylating agent.
    FOYE LV; CHAPMAN CG; WILLETT FM; ADAMS WS
    Arch Intern Med; 1960 Sep; 106():365-7. PubMed ID: 13824275
    [No Abstract]   [Full Text] [Related]  

  • 7. NITROGEN MUSTARD-RESISTANT YOSHIDA SARCOMA AND CROSS-RESISTANCE STUDIES.
    UJHAZY V; WINKLER A
    Neoplasma; 1965; 12():11-4. PubMed ID: 14278323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of immediate results in the treatment of lymphogranulomatosis with dopan and degranol].
    RAEVSKII IG
    Vopr Onkol; 1962; 8(4)():3-11. PubMed ID: 14489811
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alkylating cytostatic agents].
    Schmidt CG
    Internist (Berl); 1971; 12():Suppl 1:119-27. PubMed ID: 5002874
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of malignant disease with an alkylating agent: review of 100 patients treated with "Endoxan".
    REEVE TS
    Med J Aust; 1961 May; 48(1)():686-9. PubMed ID: 13740326
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of cytostatic alkylating agents on deoxyribonucleo protein complex of lymphatic and haemopoetic tissue.
    Matyásová J; Skalka M
    Neoplasma; 1966; 13(4):433-42. PubMed ID: 5921852
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in small intestine epithelium of albino mice caused by chronic treatment with N-mustard substances Endoxan, Trimitan and Degranol with special consideration to Paneth granule cells].
    Eisenhuth I; Geyer G
    Acta Histochem; 1966; 25(1):71-85. PubMed ID: 4962040
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE POSSIBILITY OF PROLONGING THE VIABILITY OF SKIN TRANSPLANTS IN RABBITS WITH ALKYLATING SUBSTANCES].
    POPOV VI; NEZDATNYI MM
    Patol Fiziol Eksp Ter; 1964; 8():37-9. PubMed ID: 14184390
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaco-biochemical studies on cytotoxic polyol derivatives. II. The effect of biological alkylating agents on the thermal-denaturation properties of DNA.
    Jeney A; Szabó I; Vályi-Nagy T; Szabó J; Institoris L
    Eur J Cancer (1965); 1970 Aug; 6(4):297-302. PubMed ID: 5485266
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative determination of alkylating cytostatics on TLC plate with 4-pyridinecarboxaldehyde-2-benzothiazolylhydrazone].
    Norpoth K; Addicks HW; Witting U
    Arzneimittelforschung; 1973 Nov; 23(11):1529-35. PubMed ID: 4801657
    [No Abstract]   [Full Text] [Related]  

  • 16. COMPARATIVE STUDIES OF THE ACTION OF CHEMOTHERAPEUTICS ON INDUCED AND TRANSPLANTED TUMORS.
    KELLNER B; SUGAR J
    Acta Unio Int Contra Cancrum; 1964; 20():43-4. PubMed ID: 14151955
    [No Abstract]   [Full Text] [Related]  

  • 17. NEW AND OLD DRUGS IN THE MANAGEMENT OF HODGKIN'S DISEASE.
    SAMPEY JR
    Med Times; 1964 Jun; 92():571-4. PubMed ID: 14147083
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carcinogenesis and teratogenesis. Comparative studies from the viewpoint of teratology].
    von Kreybig T
    Arzneimittelforschung; 1970 May; 20(5):591-601. PubMed ID: 4918294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemistry of antileukemic drugs].
    Bollag W
    Schweiz Med Wochenschr; 1970 Feb; 100(7):310-4. PubMed ID: 4908606
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide (Cytoxan) in acute leukemia.
    HOOGSTRATEN B
    Cancer Chemother Rep; 1962 Feb; 16():167-71. PubMed ID: 13908759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.